9P First-line (1L) osimertinib (osi) ± platinum-pemetrexed in EGFRm advanced NSCLC: FLAURA2 patient-reported outcomes (PROs)

Not yet translated Not yet translated
This article has no abstract
Epistemonikos ID: 8791e83a93140ed6d3fc2206b741f5204f4341d1
First added on: Feb 17, 2025